Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intanza vs Adjuvanted Influenza Vaccine in Elderly
NCT00554333Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2007
- Primary completion
- Dec 2007
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of IDflu in influenza (2 arms), sponsored by Sanofi. Primary endpoint: Anti-Haemagglutinin (Anti-HA) antibody titres at 21 days. Started Oct 2007; status: completed.
02
Drugs
IDflu
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00554333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00554333.